BioPhy, innovating in the drug development sector with its AI platform, announced securing $4.5 million in investment. The financial injection, led by Metodora Ventures, Audere Capital, and TRCM, along with Spark Therapeutics' co-founder Jeff Marrazzo, strengthens the company's mission to revolutionize drug discovery.

The Philadelphia-based enterprise will channel these funds towards enhancing their AI system, aiming to quicken the pace of bringing new, promising drugs to market.